Orthopedic Extremity Devices | Asia Pacific | 2018 | Market Analysis

The Asia Pacific orthopedic extremity device market will experience strong growth over the forecast period, driven by high growth in certain subsegments, such as those for reverse shoulder arthroplasty, biocomposite and all-suture anchors, and anatomic plates and screws; favorable clinical results, product innovation, and surgeon training are driving increased use of these and other orthopedic extremity devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic extremity devices in Asia Pacific across a 10-year period.

As of 2017, large global orthopedic device manufacturers held the majority of revenues in the Asia Pacific market; however, smaller and emerging companies are gaining a foothold in some countries.

What strategies are MNCs implementing to maintain shares in this market?

Which product segments should MNCs and domestic competitors focus on for growth opportunities?

How much of an impact will the increasing presence of domestic manufacturers have on ASPs?

Some technologies being launched in the orthopedic extremity device market have steep learning curves.

What strategies are companies using to increase the penetration of these technologies?

How can these technologies compete with established alternatives currently on the market?

Cost-containment efforts and domestic competition in certain segments have placed tremendous pressure on the pricing of orthopedic extremity devices, leading to price erosion.

Which device segments will face the greatest pricing pressures?

Which technologies are continuing to display revenue growth despite these pressures?